Toggle light / dark theme

Blood vessel growth factor alleviates anxious behaviors in mouse study

Posted in biotech/medical, neuroscience

Anxiety disorders, characterized by an excessive apprehension about real or perceived threats and dysfunctional behaviors aimed at avoiding these threats, are among the most common mental health conditions. Estimates suggest that around 4% of the world’s population, so a few hundred million people, experiences these disorders, which can have debilitating effects, significantly lowering their quality of life.

While there are currently various treatment options for , many existing medications do not prove effective for all individuals. Some neuroscientists worldwide have thus been trying to identify new promising neuro-biological targets for relieving anxiety and anxious behaviors.

Recent studies uncovered an association between anxiety disorders and the impaired functioning of the (BBB), a protective layer comprised of that regulates the flow of substances between the bloodstream and the brain. However, the precise neural mechanisms underpinning the link between BBB dysfunction and anxiety remain elusive.

Leave a Comment